JP2021518361A5 - - Google Patents
Info
- Publication number
- JP2021518361A5 JP2021518361A5 JP2020549641A JP2020549641A JP2021518361A5 JP 2021518361 A5 JP2021518361 A5 JP 2021518361A5 JP 2020549641 A JP2020549641 A JP 2020549641A JP 2020549641 A JP2020549641 A JP 2020549641A JP 2021518361 A5 JP2021518361 A5 JP 2021518361A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- peptide
- oligonucleotide conjugate
- acceptable salt
- chimeric peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024159928A JP2024163336A (ja) | 2018-03-16 | 2024-09-17 | アンチセンス送達用キメラペプチド |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862644202P | 2018-03-16 | 2018-03-16 | |
| US62/644,202 | 2018-03-16 | ||
| PCT/US2019/022475 WO2019178479A1 (en) | 2018-03-16 | 2019-03-15 | Chimeric peptides for antisense delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024159928A Division JP2024163336A (ja) | 2018-03-16 | 2024-09-17 | アンチセンス送達用キメラペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021518361A JP2021518361A (ja) | 2021-08-02 |
| JP2021518361A5 true JP2021518361A5 (cg-RX-API-DMAC7.html) | 2023-08-28 |
| JP7596148B2 JP7596148B2 (ja) | 2024-12-09 |
Family
ID=67908050
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020549641A Active JP7596148B2 (ja) | 2018-03-16 | 2019-03-15 | アンチセンス送達用キメラペプチド |
| JP2024159928A Pending JP2024163336A (ja) | 2018-03-16 | 2024-09-17 | アンチセンス送達用キメラペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024159928A Pending JP2024163336A (ja) | 2018-03-16 | 2024-09-17 | アンチセンス送達用キメラペプチド |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12370261B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3765030A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7596148B2 (cg-RX-API-DMAC7.html) |
| MA (1) | MA52148A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202002990A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019178479A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019079386A1 (en) * | 2017-10-17 | 2019-04-25 | Sarepta Therapeutics, Inc. | CELL PENETRATION PEPTIDES FOR ANTISENSE ADMINISTRATION |
| US20250228954A1 (en) * | 2020-01-24 | 2025-07-17 | Sarepta Therapeutics, Inc. | Designing Antisense Oligonucleotide Delivery Peptides by Interpretable Machine Learning |
| CA3211038A1 (en) * | 2021-02-12 | 2022-08-18 | Oxford University Innovation Limited | Cell-penetrating peptide conjugates and methods of their use |
| WO2026080471A2 (en) | 2024-10-07 | 2026-04-16 | Flagship Pioneering Innovations Vi, Llc | Compositions of trem conjugates and uses thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5752601A (en) | 2000-05-04 | 2001-11-12 | Avi Biopharma Inc | Splice-region antisense composition and method |
| US8129352B2 (en) | 2004-09-16 | 2012-03-06 | Avi Biopharma, Inc. | Antisense antiviral compound and method for treating ssRNA viral infection |
| AU2006267051B2 (en) | 2005-07-13 | 2013-03-07 | Sarepta Therapeutics, Inc. | Antisense antibacterial method and compound |
| LT2735568T (lt) | 2006-05-10 | 2017-11-27 | Sarepta Therapeutics, Inc. | Oligonukleotido analogai, turintys katijonines jungtis tarp subvienetų |
| US20100016215A1 (en) * | 2007-06-29 | 2010-01-21 | Avi Biopharma, Inc. | Compound and method for treating myotonic dystrophy |
| WO2009147368A1 (en) * | 2008-06-04 | 2009-12-10 | Medical Research Council | Peptides |
| AU2011367230B2 (en) | 2011-05-05 | 2017-08-10 | Sarepta Therapeutics, Inc. | Peptide oligonucleotide conjugates |
| EP2755690B1 (en) | 2011-08-04 | 2020-04-01 | Merck Sharp & Dohme B.V. | Kisspeptide-pentasaccharide conjugates |
| US9512073B2 (en) | 2011-10-27 | 2016-12-06 | Massachusetts Institute Of Technology | Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof |
| ES2727481T3 (es) | 2011-11-30 | 2019-10-16 | Sarepta Therapeutics Inc | Inclusión inducida de exón en atrofia muscular espinal |
| US10111962B2 (en) | 2012-09-25 | 2018-10-30 | Genzyme Corporation | Peptide-linked morpholino antisense oligonucleotides for treatment of myotonic dystrophy |
| WO2014124952A1 (en) | 2013-02-12 | 2014-08-21 | Syddansk Universitet | "clickable" alkyne-lna oligonucleotides |
| EP3760720A1 (en) | 2013-03-14 | 2021-01-06 | Sarepta Therapeutics, Inc. | Exon skipping compositions for treating muscular dystrophy |
| HK1220154A1 (zh) * | 2013-03-15 | 2017-04-28 | Sarepta Therapeutics, Inc. | 改进的用於治疗肌营养不良的组合物 |
| WO2015038933A1 (en) | 2013-09-13 | 2015-03-19 | California Institute Of Technology | Phosphorylated akt-specific capture agents, compositions, and methods of using and making |
| CN113105559A (zh) * | 2013-12-12 | 2021-07-13 | 生命技术公司 | 增强转染的膜穿透性肽和组合物以及其使用方法 |
| GB201421379D0 (en) | 2014-12-02 | 2015-01-14 | Isis Innovation Ltd And Medical Res Council | Molecule |
| WO2017066789A1 (en) | 2015-10-16 | 2017-04-20 | Modernatx, Inc. | Mrna cap analogs with modified sugar |
| WO2019079386A1 (en) * | 2017-10-17 | 2019-04-25 | Sarepta Therapeutics, Inc. | CELL PENETRATION PEPTIDES FOR ANTISENSE ADMINISTRATION |
| EP3829597A4 (en) * | 2018-07-30 | 2022-05-18 | Sarepta Therapeutics, Inc. | TRIMER PEPTIDES FOR ANTISENSE ADMINISTRATION |
-
2019
- 2019-03-15 EP EP19767585.3A patent/EP3765030A4/en active Pending
- 2019-03-15 MA MA052148A patent/MA52148A/fr unknown
- 2019-03-15 TW TW108108833A patent/TW202002990A/zh unknown
- 2019-03-15 JP JP2020549641A patent/JP7596148B2/ja active Active
- 2019-03-15 WO PCT/US2019/022475 patent/WO2019178479A1/en not_active Ceased
- 2019-03-15 US US16/981,145 patent/US12370261B2/en active Active
-
2024
- 2024-09-17 JP JP2024159928A patent/JP2024163336A/ja active Pending
-
2025
- 2025-06-10 US US19/233,984 patent/US20250367306A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021532784A5 (cg-RX-API-DMAC7.html) | ||
| JP2758988B2 (ja) | ペプチド核酸 | |
| US7910726B2 (en) | Amidite for synthesizing modified nucleic acid and method for synthesizing modified nucleic acid | |
| US6441130B1 (en) | Linked peptide nucleic acids | |
| JP2024506099A5 (cg-RX-API-DMAC7.html) | ||
| US8859490B2 (en) | Peptide nucleic acid monomers and oligomers | |
| Mrksich et al. | Recognition in the minor groove of DNA at 5'-(A, T) GCGC (A, T)-3'by a four ring tripeptide dimer. Reversal of the specificity of the natural product distamycin | |
| JP2024511955A5 (cg-RX-API-DMAC7.html) | ||
| Jain | Cγ-Aminopropylene peptide nucleic acid (amp-PNA): Chiral cationic PNAs with superior PNA: DNA/RNA duplex stability and cellular uptake | |
| De Cola et al. | Carboxyalkyl peptoid PNAs: synthesis and hybridization properties | |
| US8288516B2 (en) | Functional molecule, functional molecule synthesizing amidite and target substance analysis method | |
| JPWO2009028345A1 (ja) | 核酸合成用ダイマーアミダイド及び核酸合成方法 | |
| AU2020324396B2 (en) | Compositions of trofinetide | |
| CN114901673B (zh) | 溶液相肽核酸寡聚体的制备方法 | |
| Katritzky et al. | Chiral peptide nucleic acid monomers (PNAM) with modified backbones | |
| AU2022291626A1 (en) | Improved process for preparing imetelstat | |
| US10174075B2 (en) | Use of a tetraphenylborate (TPB) salt for the separation of biomolecules | |
| DE69513313T2 (de) | Verfahren zur Herstellung von Nukleinsäurebasenderivaten | |
| Hudson et al. | The detrimental effect of orotic acid substitution in the peptide nucleic acid strand on the stability of PNA2: NA triple helices | |
| JP2007511573A (ja) | 癌の治療のための置換キノリン | |
| US20210163541A1 (en) | Method for Preparing PNA Oligomer | |
| JP2023510019A5 (cg-RX-API-DMAC7.html) | ||
| WO2001066528A1 (en) | Method for storing quaternary ammonium salt | |
| KR20230109301A (ko) | 신규한 pna 단량체 및 이를 포함하는 pna 올리고머 | |
| US20050187138A1 (en) | Peptide beta-strand mimics based on pyridinones, pyrazinones, pyridazinones, and triazinones |